Gontivimab
Gontivimab Basic information
- Product Name:
- Gontivimab
- Synonyms:
-
- Gontivimab
- Research Grade Gontivimab (DVV02806)
- Research Grade Gontivimab
- CAS:
- 1257358-38-5
- MW:
- 0
- Mol File:
- Mol File
More
Less
Gontivimab Usage And Synthesis
Uses
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung[1].
in vivo
Gontivimab (1-68 mg/kg; intranasal administration or nebulization) reduces the RSV load in the nose and lungs in rats[1].
| Animal Model: | Rats (RSV Tracy)[1] |
| Dosage: | 1-68 mg/kg |
| Administration: | Intranasal administration or nebulization; once (day 2 or day 3) or twice (day 2 and day 3) |
| Result: | Resulted in significant viral load reductions in the lungs ranging. |
References
[1] Detalle L, et al. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2015 Oct 5;60(1):6-13. DOI:10.1128/AAC.01802-15
GontivimabSupplier
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
TargetMol Chemicals Inc.
- Tel
- 4008200310
- marketing@tsbiochem.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
Wuhan Jingkangen Biomedical Technology Co., Ltd
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com